About GeNouRoB
GeNouRoB is a company based in Laval (France) founded in 2007. GeNouRoB has raised $417.81 thousand across 4 funding rounds from investors including Siparex, GO CAPITAL and European Union. GeNouRoB offers products and services including GNRB, DYNEELAX, and SPINEO. GeNouRoB operates in a competitive market with competitors including Trice Medical, Edge Surgical, OrthoScan, Onicorp and Bone Index Finland, among others.
- Headquarter Laval, France
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$417.81 K (USD)
in 4 rounds
-
Latest Funding Round
$55.05 K (USD), Grant
Nov 30, 2019
-
Investors
Siparex
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GeNouRoB
GeNouRoB offers a comprehensive portfolio of products and services, including GNRB, DYNEELAX, and SPINEO.
Device for automated knee laxity and ACL injury assessment.
Motorized tool for precise ligament analysis and diagnostics.
Patented device for spine therapy and back pain management.
Funding Insights of GeNouRoB
GeNouRoB has successfully raised a total of $417.81K across 4 strategic funding rounds. The most recent funding activity was a Grant round of $55.05 thousand completed in November 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in GeNouRoB
GeNouRoB has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Siparex, GO CAPITAL and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Private equity investments are focused on growth stage companies.
|
Locked | Locked | Locked | |
|
Private equity investments are directed toward multiple sectors.
|
Locked | Locked | Locked |
Investor details for GeNouRoB
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by GeNouRoB
Investment portfolio details for GeNouRoB
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - GeNouRoB
Detailed financials for GeNouRoB
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genourob Comparisons
Peer comparison for GeNouRoB
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GeNouRoB
GeNouRoB operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Trice Medical, Edge Surgical, OrthoScan, Onicorp and Bone Index Finland, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Needle-based visualization devices for orthopedic diagnostics are developed.
|
|
| Locked | Locked | Locked |
Digital depth gauges for orthopedic bone measurements are supplied.
|
|
| Locked | Locked | Locked |
Mini C-arms for orthopedic imaging are developed by OrthoScan.
|
|
| Locked | Locked | Locked |
MRI systems for extremity imaging are developed and marketed.
|
|
| Locked | Locked | Locked |
Ultrasound-based POC device for osteoporosis screening is developed.
|
|
| Locked | Locked | Locked |
Robotic surgical systems for orthopedic treatments are provided.
|
Detailed competitors of GeNouRoB
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genourob
Complete news archive for GeNouRoB
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GeNouRoB
GeNouRoB was founded in 2007 and raised its 1st funding round 4 years after it was founded.
GeNouRoB is headquartered in Laval, France.
GeNouRoB is a funded company, having raised a total of $417.81K across 4 funding rounds to date.
Founded in 2007 in Laval, France, the company focuses on the medical devices sector. Devices and associated software are designed, produced, and marketed for assessing knee ligament structures and performance. Automated dynamic laximetry tools are utilized to measure laxity through standardized tests. Products are distributed in over 18 countries, supporting clinical evaluations and rehabilitation processes.
GeNouRoB's top competitors include Edge Surgical, Trice Medical and Echolight Medical.
GeNouRoB offers GNRB, DYNEELAX, and SPINEO.
GeNouRoB has 4 investors. Key investors include Siparex, GO CAPITAL, European Union, and EIC Fund.